Loading...
Cryo-Cell International, Inc.
CCEL•NASDAQ
HealthcareMedical - Care Facilities
$4.94
$-0.07(-1.42%)
Cryo-Cell International, Inc. (CCEL) Financial Performance & Statements
Review Cryo-Cell International, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
2.05%
↑ 2.05%
Operating Income Growth
128.29%
↑ 128.29%
Net Income Growth
104.22%
↑ 104.22%
Operating Cash Flow Growth
-32.61%
↓ 32.61%
Operating Margin
11.57%
↑ 11.57%
Gross Margin
75.79%
↑ 75.79%
Net Profit Margin
0.40%
↑ 0.40%
ROE
-1.07%
↓ 1.07%
ROIC
8.71%
↑ 8.71%
Cryo-Cell International, Inc. (CCEL) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Cryo-Cell International, Inc. stock.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $7.97M | $8.02M | $8.07M | $8.04M |
| Cost of Revenue | $1.98M | $1.64M | $2.13M | $2.02M |
| Gross Profit | $5.98M | $6.39M | $5.94M | $6.02M |
| Gross Profit Ratio | $0.75 | $0.80 | $0.74 | $0.75 |
| R&D Expenses | $98143.00 | $304629.00 | $193933.00 | $241085.00 |
| SG&A Expenses | $4.64M | $6.01M | $4.15M | $4.02M |
| Operating Expenses | $4.93M | $6.51M | $4.55M | $4.32M |
| Total Costs & Expenses | $6.91M | $8.15M | $6.68M | $6.35M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | -$494962.00 | $745488.00 | $533464.00 | $329273.00 |
| Depreciation & Amortization | $191853.00 | $339448.00 | $332472.00 | $188495.00 |
| EBITDA | $230609.00 | $242502.00 | $384588.00 | $1.99M |
| EBITDA Ratio | $0.03 | $0.03 | $0.05 | $0.25 |
| Operating Income | $1.06M | -$122347.00 | $1.39M | $1.39M |
| Operating Income Ratio | $0.13 | -$0.02 | $0.17 | $0.17 |
| Other Income/Expenses (Net) | -$522293.00 | -$720087.00 | -$10025.00 | -$735728.00 |
| Income Before Tax | $533718.00 | -$842434.00 | $1.38M | $1.47M |
| Income Before Tax Ratio | $0.07 | -$0.10 | $0.17 | $0.18 |
| Income Tax Expense | -$250863.00 | $1.02M | $328186.00 | $816390.00 |
| Net Income | $784581.00 | -$1.86M | $1.05M | $655790.00 |
| Net Income Ratio | $0.10 | -$0.23 | $0.13 | $0.08 |
| EPS | $0.03 | -$0.23 | $0.13 | $0.08 |
| Diluted EPS | $0.03 | -$0.23 | $0.13 | $0.08 |
| Weighted Avg Shares Outstanding | $8.08M | $8.13M | $8.06M | $8.12M |
| Weighted Avg Shares Outstanding (Diluted) | $8.20M | $8.21M | $8.17M | $8.23M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan